MAMEM consortium had the pleasure to host Dr. Henk Seelen from Adelante Centre of Expertise in Rehabilitation and Audiology & University Maastricht, Prof. Avi Ohry from Tel Aviv University – Department of Rehabilitation Medicine, and Prof. Dr.-Ing. Erhardt Barth (via Skype) from the Department of Neuro- and Bioinformatics, University of Lübeck. During the presentation of the project a number of important recommendations was provided, ranging from the statistical significance of Phase I trials and the emphasis that should be given on descriptive statistics rather than regular statistics, all the way to the negative side-effects that may have appeared during the execution of the trials, and the added (commercial value) that should be made mode clear and concrete during the remaining of the project.
We definitely look forward to the written feedback!